Among the biomarkers in the 14-Gene Panel used, VEGFA, PTEN, PIP5K1A, CDK1, and CCND1 were found to have significant differential gene expression in urinary samples between the lower- and higher-risk PCa patients. This evidence concerns the gene VEGFA and posterior cortical atrophy.